Cargando…

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)

Schizophrenia is composed of a heterogeneous group of patient segments. Our current notion of the heterogeneity in schizophrenia is based on patients presenting with diverse disease symptom phenotypes, risk factors, structural and functional neuropathology, and a mixed range of expressed response to...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kinon, Bruce J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363683/ https://www.ncbi.nlm.nih.gov/pubmed/30761026 http://dx.doi.org/10.3389/fpsyt.2018.00757

Ejemplares similares

Concept and Management of Treatment Resistant Schizophrenia (TRS)
por: Painuly, Nitesh, et al.
Publicado: (2004)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Distinguishing Between Treatment-Resistant and Non-Treatment-Resistant Schizophrenia Using Regional Homogeneity
por: Gao, Shuzhan, et al.
Publicado: (2018)

Treatment-resistant schizophrenia: How far have we traveled?
por: Pandey, Ambu, et al.
Publicado: (2022)

Characterization of “Responder” in patients with Treatment-Resistant Schizophrenia (TRS) treated with a new antipsychotic added to their current antipsychotic monotherapy
por: Anand, R., et al.
Publicado: (2023)

Altered Neuroanatomical Signatures of Patients With Treatment-Resistant Schizophrenia Compared to Patients With Early-Stage Schizophrenia and Healthy Controls
por: Liu, Congcong, et al.
Publicado: (2022)

Magnetic Seizure Therapy in Treatment-Resistant Schizophrenia: A Pilot Study
por: Tang, Victor M., et al.
Publicado: (2018)

Targeting Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia with fMRI-Based Neurofeedback – Exploring Different Cases of Schizophrenia
por: Dyck, Miriam S., et al.
Publicado: (2016)

The heterogeneity of antipsychotic response in the treatment of schizophrenia
por: Case, M., et al.
Publicado: (2011)

Dissociative Model in Patients With Resistant Schizophrenia
por: Panov, Georgi
Publicado: (2022)

Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics
por: MacKay, Mary-Anne B., et al.
Publicado: (2018)

Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine
por: Kikuchi, Masataka, et al.
Publicado: (2021)

Managing treatment resistance in schizophrenia: A joint study in Hong Kong and Singapore
por: Zheng, Shushan, et al.
Publicado: (2022)

Higher brain structural heterogeneity in schizophrenia
por: Fang, Keke, et al.
Publicado: (2022)

Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View
por: Leung, Cheryl Cheuk-Yan, et al.
Publicado: (2019)

Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

Obsessive-compulsive symptoms in patient with schizophrenia: The influence of disorganized symptoms, duration of schizophrenia, and drug resistance
por: Panov, Georgi, et al.
Publicado: (2023)

The Role of Inflammation in the Treatment of Schizophrenia
por: Fond, Guillaume, et al.
Publicado: (2020)

Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis
por: Polese, Daniela, et al.
Publicado: (2019)

Editorial: Neurobiology, Clinical Course, and Therapeutic Approaches of Treatment-Resistant Schizophrenia: Toward an Integrated View
por: Iasevoli, Felice, et al.
Publicado: (2019)

Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2017)

Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2020)

A Case Study Demonstrating Applications of ChatGPT in the Clinical Management of Treatment-Resistant Schizophrenia
por: Galido, Pearl Valentine, et al.
Publicado: (2023)

Case report: Treatment-resistant schizophrenia with auto-aggressive compulsive behavior—Successful management with cariprazine
por: Renemane, Lubova, et al.
Publicado: (2023)

Comparative Analysis of Lateral Preferences in Patients With Resistant Schizophrenia
por: Panov, Georgi
Publicado: (2022)

Targeted Intermittent Treatment in Chronic Schizophrenia
por: Sfera, Adonis
Publicado: (2013)

Pharmacotherapy for treatment-resistant schizophrenia
por: Mcilwain, Meghan E, et al.
Publicado: (2011)

Caregiver Burdens Associated With Treatment-Resistant Schizophrenia: A Quantitative Caregiver Survey of Experiences, Attitudes, and Perceptions
por: Velligan, Dawn I., et al.
Publicado: (2019)

Altered glutamate level and its association with working memory among patients with treatment-resistant schizophrenia (TRS): a proton magnetic resonance spectroscopy study
por: Huang, Li-Chung, et al.
Publicado: (2023)

Gender-associated role in patients with schizophrenia. Is there a connection with the resistance?
por: Panov, Georgi
Publicado: (2022)

Ursodeoxycholic Acid in Patients With Treatment-Resistant Schizophrenia Suffering From Coronavirus Disease 2019: A Hypothesis Letter
por: Khosravi, Mohsen
Publicado: (2021)

Electrophysiological Evidence in Schizophrenia in Relation to Treatment Response
por: Sueyoshi, Kazuki, et al.
Publicado: (2018)

Editorial: The Role of Inflammation in the Etiology and Treatment of Schizophrenia
por: Köhler-Forsberg, Ole, et al.
Publicado: (2020)

Markers of muscarinic deficit for individualized treatment in schizophrenia
por: Stuke, Heiner
Publicado: (2023)

Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2021)

Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms
por: Soontornniyomkij, Virawudh, et al.
Publicado: (2019)

Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
por: Tseng, Ping-Tao, et al.
Publicado: (2022)

Vitamin D Levels in Different Severity Groups of Schizophrenia
por: Akinlade, Kehinde Sola, et al.
Publicado: (2017)

Gender Differences in the Psychopharmacological Treatment of Forensic In-Patients With Schizophrenia
por: Mayer, Juliane, et al.
Publicado: (2022)

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
por: Faries, Douglas E, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nc9t6dd1fvahgfmtf7ago1i2sg